Kinsale Capital Group, Inc.
KNSL
$328.43
+6.48%
Kinsale Capital Group, Inc. is an insurance holding company specializing in commercial excess and surplus (E&S) lines property, casualty, and specialty insurance. The company operates as a disciplined, technology-enabled underwriter in a niche segment of the insurance market, distinguishing itself through a focus on small and medium-sized accounts and a low-expense operating model. The current investor narrative centers on the stock's significant price correction from previous highs, driven by concerns over valuation and potential normalization in the hard insurance market cycle, as evidenced by recent analyst downgrades and a sharp year-over-year share price decline.…
KNSL
Kinsale Capital Group, Inc.
$328.43
KNSL 12-Month Price Forecast
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Kinsale Capital Group, Inc.'s 12-month outlook, with a consensus price target around $426.96 and implied upside of +30.0% versus the current price.
Average Target
$426.96
2 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
2
covering this stock
Price Range
$263 - $427
Analyst target range
Analyst coverage is limited, with only 2 analysts providing estimates, indicating this is a smaller-cap stock with less institutional research focus, which can contribute to higher volatility. The consensus sentiment appears mixed based on recent institutional actions, with one upgrade to Buy from Truist but also downgrades to Underperform from Jefferies and BMO Capital in early 2026, reflecting high uncertainty and debate over the stock's prospects. Without explicit price targets provided in the data, the implied upside or downside cannot be calculated, but the wide dispersion in recent rating actions signals a lack of conviction and highlights the stock's contested investment narrative following its steep decline.
Bulls vs Bears: KNSL Investment Factors
The evidence presents a classic battle between deteriorating price momentum and robust underlying fundamentals. The bearish case, led by the severe 34% price decline, negative analyst sentiment shifts, and valuation de-rating, currently holds stronger near-term evidence as the market reprices the stock for a less favorable cycle. However, the bullish case is underpinned by exceptionally strong profitability, growth, and balance sheet metrics that are largely intact. The single most important tension in the investment debate is whether the market's de-rating (from a P/E >30x to ~18x) has overshot the reality of a potential cyclical slowdown, or if it correctly anticipates a material decline in KNSL's premium growth and underwriting margins. The resolution of this tension will determine if the stock is a deep value opportunity or a value trap.
Bullish
- Exceptional Profitability and Margins: KNSL's Q4 2025 net margin was 26.87% and its operating margin was 33.85%, demonstrating highly efficient underwriting and operational discipline. This superior profitability, driven by a 55.88% gross margin, provides a significant competitive moat and strong cash generation.
- Robust Revenue Growth: The company continues to deliver strong top-line expansion, with Q4 2025 revenue of $483.27 million representing a 17.26% year-over-year increase. This growth is consistent and underpins the company's premium valuation, even amidst a market de-rating.
- Strong Balance Sheet and Cash Flow: KNSL has a fortress-like balance sheet with a low debt-to-equity ratio of 0.11 and a stellar return on equity of 25.70%. The company generated $990.05 million in trailing free cash flow, providing ample financial flexibility for growth and shareholder returns.
- Attractive Forward Valuation: The stock's forward P/E of 14.33x represents a significant discount to its own historical multiples, which have been above 30x. This forward multiple is now more in line with a value proposition given the company's high growth and profitability profile.
Bearish
- Severe Price and Sentiment Downtrend: KNSL is down 34.30% over the past year, significantly underperforming the S&P 500's 22.86% gain. This reflects a major de-rating and a shift in market narrative away from its previously premium valuation, with recent analyst downgrades to Underperform highlighting the negative momentum.
- Valuation Compression and Cycle Concerns: The stock's trailing P/E has compressed from over 30x to 17.97x, signaling the market is pricing in a normalization of the hard insurance market cycle. The Price/Sales ratio of 4.83x, while lower than its peak, remains elevated and could face further pressure if growth decelerates.
- Limited Analyst Coverage and Conviction: With only 2 analysts providing estimates, the stock suffers from low institutional research visibility, which can exacerbate volatility. The recent mixed actions (one Buy, two Underperform downgrades) indicate a high degree of uncertainty and a lack of consensus on the path forward.
- Sector and Macro Headwinds: As a property & casualty insurer, KNSL is exposed to potential increases in claims severity and frequency. The stock's 40.76% maximum drawdown shows its vulnerability to sector-wide rotations and fears of a deteriorating underwriting environment, despite its current strong margins.
KNSL Technical Analysis
The stock is in a pronounced downtrend, with a 1-year price change of -34.30%, indicating a sustained bearish phase. Currently trading at $311.38, the price is positioned near the lower end of its 52-week range of $287.20 to $512.76, sitting at approximately 14% above the 52-week low, which suggests the stock may be approaching oversold territory but remains under significant pressure. Recent momentum shows a mixed short-term picture, with a 1-month gain of 3.63% but a 3-month decline of -14.11%, indicating a potential stabilization attempt after a severe sell-off, though the longer-term trend remains decisively negative. The stock's beta of 0.913 indicates it has been slightly less volatile than the broader market during this period, which is notable given its steep decline. Key technical levels are clear, with immediate support at the 52-week low of $287.20 and formidable resistance at the 52-week high of $512.76; a sustained break below support could signal further downside, while a recovery above the recent trading range would be needed to suggest a trend reversal.
Beta
0.91
0.91x market volatility
Max Drawdown
-40.8%
Largest decline past year
52-Week Range
$287-$513
Price range past year
Annual Return
-31.1%
Cumulative gain past year
| Period | KNSL Return | S&P 500 |
|---|---|---|
| 1m | +7.3% | -2.9% |
| 3m | +0.3% | +15.0% |
| 6m | -16.5% | +5.6% |
| 1y | -31.1% | +19.1% |
| ytd | -16.3% | +6.9% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
KNSL Fundamental Analysis
Revenue growth remains robust, with Q4 2025 revenue of $483.27 million representing a 17.26% year-over-year increase, continuing a multi-quarter trend of strong top-line expansion driven by premium growth in its E&S lines segment. Profitability is exceptional, with the company reporting net income of $138.62 million for Q4 2025 and a trailing net margin of 26.87%, supported by a gross margin of 55.88% and an operating margin of 33.85%, showcasing highly efficient underwriting and operational discipline. The balance sheet and cash flow are very healthy, with a low debt-to-equity ratio of 0.11, a strong return on equity of 25.70%, and robust trailing twelve-month free cash flow of $990.05 million, indicating the company generates ample cash to fund operations and growth internally without financial strain.
Quarterly Revenue
$483271000.0B
2025-12
Revenue YoY Growth
+0.17%
YoY Comparison
Gross Margin
+0.55%
Latest Quarter
Free Cash Flow
$990053000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Open an Account, get $2 TSLA now!
Valuation Analysis: Is KNSL Overvalued?
Given a positive net income, the primary valuation metric is the P/E ratio. The trailing P/E is 17.97x, while the forward P/E is 14.33x; the lower forward multiple suggests the market anticipates continued earnings growth. Compared to sector averages, the stock's trailing P/E of 17.97x and Price/Sales of 4.83x are not directly comparable without a provided industry benchmark, but the company's premium valuation historically reflected its superior growth and profitability profile. Historically, the current trailing P/E of 17.97x is below its own recent historical range, which has seen multiples above 30x in early 2024, indicating a significant de-rating and suggesting the market has priced in a more conservative outlook on future growth or margin sustainability.
PE
18.0x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 16x~48x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
14.0x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: KNSL's primary financial risk is not leverage or cash burn—its debt-to-equity of 0.11 and $990M in TTM FCF are strong—but rather its dependence on sustaining exceptional profitability to justify its valuation. A compression of its net margin from the current 26.87% towards industry averages would significantly impact earnings growth. Furthermore, the company operates in a single segment (Excess and Surplus Lines), creating revenue concentration risk. While Q4 revenue grew 17.26% YoY, any deceleration below market expectations could trigger further multiple contraction given the stock's still-elevated Price/Sales of 4.83x.
Market & Competitive Risks: The stock faces significant valuation compression risk, having already de-rated from a P/E above 30x to 17.97x. If the hard insurance market cycle softens, leading to increased competition and lower premium pricing power, the stock's premium valuation (P/S of 4.83x, EV/EBITDA of 14.00x) could compress further. The stock's beta of 0.913 suggests it is slightly less volatile than the market, but its 40.76% max drawdown and severe underperformance (-57.16% relative strength vs. SPY over 1 year) indicate it is highly sensitive to sector-specific sentiment and growth stock rotations, independent of broader market moves.
Worst-Case Scenario: The worst-case scenario involves a combination of a rapid softening in the E&S insurance market, leading to a sharp deceleration in premium growth (from 17% to low single digits) and concurrent margin pressure from increased claims. This would trigger a wave of analyst downgrades and earnings estimate cuts. In this adverse scenario, the stock could re-test and break below its 52-week low of $287.20, representing a -7.8% decline from the current price. A more severe bear case, factoring in a return to its historical lower-end valuation multiples, could see a drawdown approaching -20% to -25% from current levels, especially if the high short interest fuels a downward spiral.